Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous natural killer cells (1 trial)
Carcinoma, Hepatocellular (Phase 1)
Colonic Neoplasms (Phase 1)
Glioma (Phase 1)
Liver Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Prostatic Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (1 total)